FDA panel recommends first biosimilar approval
Modern Healthcare - January 7, 2015
A federal advisory panel has recommended that the government approve a Novartis cancer drug as a biosimilar alternative to Amgen's Neupogen, which could be the first such designation in a new process intended to foster competition for some of the most expensive drugs in healthcare.
FDA Drug Approvals Reached 18 Year High in 2014
Associated Press - January 2, 2015
The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years.
Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts
HealthDay News - December 23, 2014
New guidelines from the American Diabetes Association (ADA) call for giving the cholesterol-lowering drugs known as statins to all people with diabetes to help prevent heart disease.
Analysts expect M&A frenzy to continue with deals by Pfizer, AbbVie, Valeant likely in 2015
FiercePharma - January 7, 2015
Cheap money, momentum and need for growth will continue to fuel buyouts, they say
Wearable, Doc-Prescribed Monitors May Help Spot High Blood Pressure
HealthDay News - December 22, 2014
People suspected of having high blood pressure may soon be asked to wear what's known as an "ambulatory" blood pressure monitor for a day or so to confirm the diagnosis, according to draft recommendations issued by the U.S. Preventive Services Task Force.
What Lies Ahead for Healthcare Reform?
Healthcare Financial Management Association - January 01, 2015
Although hypertension and diabetes are often comorbid conditions, nearly one-third of hypertensive patients have not had their blood sugar tested in the last 3 years, according to research published online in Preventing Chronic Disease on November 26, 2014.
Medicare Cuts Payments To 721 Hospitals With Highest Rates Of Infections, Injuries
Kaiser Health News - December 18, 2014
In its toughest crackdown yet on medical errors, the federal government is cutting payments to 721 hospitals for having high rates of infections and other patient injuries, records released Thursday show.
Calif. group working to reduce Rx overdoses
Drug Topics - January 05, 2015
Several state agencies in California are combining resources to create strategies to prevent deaths and injuries from prescription-painkiller overdoses.
Type 2 diabetes risk varies with magnesium intake, genes and ethnicity
ScienceDaily - January 7, 2015
A new study investigated the complex interactions between magnesium intake, genes and ethnicity in determining risk for type 2 diabetes in two populations of women. The specific associations yielded by the analysis illustrate how health guidance could become considerably more personalized.
Contact,
Jan Tankersley
Senior Vice President, Marketing & Sales
Pharmaceutical Strategies Group (PSG)
Office: 972-943-7141
Email: JTankersley@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |